ANO1 and cystic fibrosis: These findings will contribute to broaden our knowledge of the role that TMEM16A plays in the airways, with an impact on how it may be used as a drug target for CF and also for other airway obstructive pulmonary diseases (Sondo et al, 2014; Brett, 2015; Sala-Rabanal et al, 2015).